Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, D-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice

Psychopharmacology

Volumn 174, Issue 2, 2004, Pages 266-273

  Mcgeehan, Andrew J ^a   Janak, Patricia H ^a   Olive, M Foster ^a  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

Author keywords

Cocaine; D amphetamine; Dopamine reuptake inhibitor; GBR12909; Locomotor activity; Metabotropic glutamate receptor; mGluR5; MPEP; Psychostimulant

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; COCAINE; DEXAMPHETAMINE; METABOTROPIC RECEPTOR ANTAGONIST; VANOXERINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL MONITORING; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; HYPERACTIVITY; LOCOMOTION; MALE; MONOSYNAPTIC PATHWAY; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY;

EID: 3142737454     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1733-2     Document Type: Article

References (89)

1. Abe T, Sugihara H, Nawa H, Shigemoto R, Mizuno N, Nakanishi S (1992) Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction. J Biol Chem 267:13361-13368
2. Adriani W, Felici A, Sargolini F, Roullet P, Usiello A, Oliverio A, Mele A (1998) N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes. Exp Brain Res 123:52-59
3. Andersen PH (1989) The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur J Pharmacol 166:493-504
4. Anderson JJ, Rao SP, Rowe B, Giracello DR, Holtz G, Chapman DF, Tehrani L, Bradbury MJ, Cosford ND, Varney MA (2002) [3H]Methoxymethyl-3-[(2-methyl-1,3- thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization. J Pharmacol Exp Ther 303:1044-1051
5. Anisman H, Cygan D (1975) Central effects of scopolamine and (+)-amphetamine on locomotor activity: interaction with strain and stress variables. Neuropharmacology 14:835-840
6. Attarian S, Amalric M (1997) Microinfusion of the metabotropic glutamate receptor agonist 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid into the nucleus accumbens induces dopamine-dependent locomotor activation in the rat. Eur J Neurosci 9:809-816
7. Azar MR, Acar N, Erwin VG, Barbato GF, Morse AC, Heist CL, Jones BC (1998) Distribution and clearance of cocaine in brain is influenced by genetics. Pharmacol Biochem Behav 59:637-640
8. Berger P, Elsworth JD, Arroyo J, Roth RH (1990) Interaction of [3H] GBR 12935 and GBR 12909 with the dopamine uptake complex in nucleus accumbens. Eur J Pharmacol 177:91-94
9. Browman KE, Kantor L, Richardson S, Badiani A, Robinson TE, Gnegy ME (1998) Injection of the protein kinase C inhibitor Ro31-8220 into the nucleus accumbens attenuates the acute response to amphetamine: tissue and behavioral studies. Brain Res 814:112-119
10. Cabib S (1993) Strain-dependent behavioural sensitization to amphetamine: role of environmental influences. Behav Pharmacol 4:367-374
11. Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, Tacconi S, Corsi M, Orzi F, Conquet F (2001) Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 4:873-874
12. Conn PJ, Pin J-P (1997) Pharmacology and functions of metabotropic glutamate receptors. Ann Rev Pharmacol Toxicol 37:205-237
13. Cosford ND, Tehrani L, Roppe J, Schwieger E, Smith ND, Anderson J, Bristow L, Brodkin J, Jiang X, McDonald I, Rao S, Washburn M, Varney MA (2003) 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. J Med Chem 46:204-206
14. David HN, Abraini JH (2001a) Differential modulation of the D1-like- and D2-like dopamine receptor-induced locomotor responses by group II metabotropic glutamate receptors in the rat nucleus accumbens. Neuropharmacology 41:454-463
15. David HN, Abraini JH (2001b) The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D1-like, but not D2-like, dopamine receptors in the rat nucleus accumbens. Eur J Neurosci 13:2157-2164
16. David HN, Abraini JH (2002) Group III metabotropic glutamate receptors and D1-like and D2-like dopamine receptors interact in the rat nucleus accumbens to influence locomotor activity. Eur J Neurosci 15:869-875
17. David HN, Abraini JH (2003) Blockade of the locomotor stimulant effects of amphetamine by group I, group II, and group III metabotropic glutamate receptor ligands in the rat nucleus accumbens: possible interactions with dopamine receptors. Neuropharmacology 44:717-727
18. De Blasi A, Conn PJ, Pin J, Nicoletti F (2001) Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol Sci 22:114-120
19. Del Arco A, González-Mora JL, Armas VR, Mora F (1999) Amphetamine increases the extracellular concentration of glutamate in striatum of the awake rat: involvement of high-affinity transporter mechanisms. Neuropharmacology 38:943-954
20. Delfs JM, Schreiber L, Kelley AE (1990) Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. J Neurosci 10:303-310
21. Díaz-Cabiale Z, Vivó M, Del Arco A, O'Connor WT, Harte MK, Müller CE, Martínez E, Popoli P, Fuxe K, Ferré S (2002) Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A2A and dopamine D2 receptors. Neurosci Lett 324:154-158
22. Epping-Jordan MP (2003) The role of mGluR5 in the effects of cocaine - implications for medication development. In: Herman BH (ed) Glutamate and addiction. Humana Press, Totowa, NJ, pp 271-277
23. Freed WJ (1994) Glutamatergic mechanisms mediating stimulant and antipsychotic drug effects. Neurosci Biobehav Rev 18:111-120
24. Gasparini F, Lingenhohl K, Stoehr N, Flor PJ, Heinrich M, Vranesic I, Biollaz M, Allgeier H, Heckendorn R, Urwyler S, Varney MA, Johnson EC, Hess SD, Rao SP, Sacaan AI, Santori EM, Velicelebi G, Kuhn R (1999) 2-Methyl-6- (phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 38:1493-1503
25. Giros B, Jaber M, Jones SR, Wightman R, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612
26. Gold LH, Geyer MA, Koob GF (1989) Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs. NIDA Res Monogr 94:101-126
27. Henry SA, Lehmann-Masten V, Gasparini F, Geyer MA, Markou A (2002) The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity. Neuropharmacology 43:1199-1209
28. Hermans E, Challiss RA (2001) Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. Biochem J 359:465-484
29. Heron C, Costentin J, Bonnet JJ (1994) Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier. Eur J Pharmacol 264:391-398
30. Johanson CE, Fischman MW (1989) The pharmacology of cocaine related to its abuse. Pharmacol Rev 41:3-52
31. Kalivas PW, Nakamura M (1999) Neural systems for behavioral activation and reward. Curr Opin Neurobiol 9:223-227
32. Kalivas PW, Churchill L, Romanides A (1999) Involvement of the pallidal-thalamocortical circuit in adaptive behavior. Ann N Y Acad Sci 877:64-70
33. Kantor L, Gnegy ME (1998) Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J Pharmacol Exp Ther 284:592-598
34. Karler R, Calder LD (1992) Excitatory amino acids and the actions of cocaine. Brain Res 582:143-146
35. Karler R, Calder LD, Chaudhry IA, Turkanis SA (1989) Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci 45:599-606
36. Kim JH, Vezina P (1997) Activation of metabotropic glutamate receptors in the rat nucleus accumbens increases locomotor activity in a dopamine-dependent manner. J Pharmacol Exp Ther 283:962-968
37. Kim JH, Vezina P (1998) Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. J Pharmacol Exp Ther 284:317-322
38. Kim JH, Beeler JA, Vezina P (2000) Group II, but not group I, metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. Neuropharmacology 39:1692-1699
39. Kinney GG, Burno M, Campbell UC, Hernandez LM, Rodriguez D, Bristow LJ, Conn PJ (2003) Metabotropic glutamate subtype 5 receptors (mGluR5) modulate locomotor activity and sensorimotor gating in rodents. J Pharmacol Exp Ther 306:116-123
40. Kitahama K, Valatx JL (1979) Strain differences in amphetamine sensitivity in mice. I. A diallel analysis of open field activity. Psychopharmacology 66:189-194
41. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184
42. Koob GF (1999) The role of the striatopallidal and extended amygdala systems in drug addiction. Ann N Y Acad Sci 877:445-460
43. Kuhn R, Pagano A, Stoehr N, Vranesic I, Flor PJ, Lingenhöhl K, Spooren W, Gentsch C, Vassout A, Pilc A, Gasparini F (2002) In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article. Amino Acids 23:207-211
44. Lu XY, Ghasemzadeh MB, Kalivas PW (1999) Expression of glutamate receptor subunit/subtype messenger RNAS for NMDAR1, GLuR1, GLuR2 and mGLuR5 by accumbal projection neurons. Brain Res Mol Brain Res 63:287-296
45. Mathiesen JM, Svendsen N, Brauner-Osborne H, Thomsen C, Ramirez MT (2003) Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP. Br J Pharmacol 138:1026-1030
46. Mcgeehan AJ, Olive MF (2003) The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. Synapse 47:240-242
47. Meeker D, Kim JH, Vezina P (1998) Depletion of dopamine in the nucleus accumbens prevents the generation of locomotion by metabotropic glutamate receptor activation. Brain Res 812:260-264
48. Miller DW, Abercrombie ED (1996) Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats. Brain Res Bull 40:57-62
49. Moghaddam B, Bolinao ML (1994) Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: implications for tonic influence of glutamate on dopamine release. Synapse 18:337-342
50. Nadlewska A, Car H, Wisniewska RJ, Wisniewski K (2002) Behavioral effects of the selective blockade of metabotropic glutamate receptor subtype 5 in experimental hypoxia. Pol J Pharmacol 54:95-102
51. Neisewander JL, O'Dell LE, Redmond JC (1995) Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion. Brain Res 671:201-212
52. O'Leary DM, Movsesyan V, Vicini S, Faden AI (2000) Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism. Br J Pharmacol 131:1429-1437
53. Ossowska K, Konieczny J, Wolfarth S, Wieronska J, Pilc A (2001) Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats. Neuropharmacology 41:413-420
54. Paquet M, Smith Y (2003) Group I metabotropic glutamate receptors in the monkey striatum: subsynaptic association with glutamatergic and dopaminergic afferents. J Neurosci 23:7659-7669
55. Pintor A, Pezzola A, Reggio R, Quarta D, Popoli P (2000) The mGlu5 receptor agonist CHPG stimulates striatal glutamate release: possible involvement of A2A receptors. Neuroreport 11:3611-14
56. 3H] WIN 35,428 binding to dopamine uptake sites in vivo more rapidly than mazindol or GBR 12909. Eur J Pharmacol 198:203-205
57. Pudiak CM, Bozarth MA (1993) L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci 53:1517-1524
58. Ralph RJ, Paulus MP, Geyer MA (2001) Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice. J Pharmacol Exp Ther 298:148-155
59. Reid MS, Berger SP (1996) Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. Neuroreport 7:1325-1329
60. Reid MS, Hsu KJ, Berger SP (1997) Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse 27:95-105
61. Rockhold RW (1998) Glutamatergic involvement in psychomotor stimulant action. Progr Drug Res 50:155-192
62. Romano C, Sesma MA, McDonald CT, O'Malley K, Van den Pol AN, Olney JW (1995) Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol 355:455-469
63. Rothman RB, Grieg N, Kim A, De Costa BR, Rice KC, Carroll FI, Pert A (1992) Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter. Pharmacol Biochem Behav 43:1135-1142
64. Ruth JA, Ullman EA, Collins AC (1988) An analysis of cocaine effects on locomotor activities and heart rate in four inbred mouse strains. Pharmacol Biochem Behav 29:157-162
65. Schmidt CJ, Fadayel GM (1996) Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade. J Pharmacol Exp Ther 277:1541-1549
66. Scale TW, Carney JM (1991) Genetic determinants of susceptibility to the rewarding and other behavioral actions of cocaine. J Addict Dis 10:141-162
67. Shigemoto R, Mizuno N (2000) Metabotropic glutamate receptors - immunocytochemical and in situ hybridization analysis. In: Ottersen OP, Storm-Mathisen J (eds) Handbook of chemical neuroanatomy: metabotropic glutamate receptors: immunocytochemical and in situ hybridization analyses. Elsevier, London, pp 63-98
68. Shigemoto R, Nomura S, Ohishi H, Sugihara H, Nakanishi S, Mizuno N (1993) Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett 163:53-57
69. Shoblock JR, Sullivan EB, Maisonneuve IM, Glick SD (2003) Neurochemical and behavioral differences between D-methamphetamine and D-amphetamine in rats. Psychopharmacology 165:359-369
70. 5 receptor antagonist 2-methyl-6-(phenylethynyl)- pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats. Eur J Pharmacol 406:403-410
71. Spooren WP, Vassout A, Neijt HC, Kuhn R, Gasparini F, Roux S, Porsolt RD, Gentsch C (2000b) Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J Pharmacol Exp Ther 295:1267-1275
72. Swanson CJ, Baker DA, Carson D, Worley PF, Kalivas PW (2001) Repeated cocaine administration attenuates group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: a potential role for Homer. J Neurosci 21:9043-9052
73. Swerdlow NR, Vaccarino FJ, Amalric M, Koob GF (1986) The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings. Pharmacol Biochem Behav 25:233-248
74. Testa CM, Standaert DG, Young AB, Penney JB Jr (1994) Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J Neurosci 14:3005-3018
75. Thomas LS, Jane DE, Gasparini F, Croucher MJ (2001) Glutamate release inhibiting properties of the novel mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP): complementary in vitro and in vivo evidence. Neuropharmacology 41:523-527
76. Tolliver BK, Carney JM (1994) Comparison of cocaine and GBR 12935: effects on locomotor activity and stereotypy in two inbred mouse strains. Pharmacol Biochem Behav 48:733-739
77. Uzbay IT, Wallis CJ, Lal H, Forster MJ (2000) Effects of NMDA receptor blockers on cocaine-stimulated locomotor activity in mice. Behav Brain Res 108:57-61
78. Vanderschuren LJ, Kalivas PW (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151:99-120
79. Verma A, Moghaddam B (1998) Regulation of striatal dopamine release by metabotropic glutamate receptors. Synapse 28:220-226
80. Vezina P, Kim J-H (1999) Metabotropic glutamate receptors and the generation of locomotor activity: interactions with midbrain dopamine. Neurosci Biobehav Rev 23:577-589
81. Wang JQ, McGinty JF (1999) Glutamate-dopamine interactions mediate the effects of psychostimulant drugs. Addict Biol 4:141-150
82. Witkin JM (1993) Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists. Life Sci 53:L405-L410
83. Wolf ME (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Progr Neurobiol 54:679-720
84. Wolf ME, Xue CJ, White FJ, Dahlin SL (1994) MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens. Brain Res 666:223-231
85. Womer DE, Jones BC, Erwin VG (1994) Characterization of dopamine transporter and locomotor effects of cocaine, GBR 12909, epidepride, and SCH 23390 in C57BL and DBA mice. Pharmacol Biochem Behav 48:327-335
86. Zahniser NR, Larson GA, Gerhardt GA (1999) In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors. J Pharmacol Exp Ther 289:266-277
87. Zhang Y, Loonam TM, Noailles PA, Angulo JA (2001) Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann N Y Acad Sci 937:93-120
88. Zigmond MJ, Castro SL, Keefe KA, Abercrombie ED, Sved AF (1998) Role of excitatory amino acids in the regulation of dopamine synthesis and release in the neostriatum. Amino Acids 14:57-62
89. Zocchi A, Orsini C, Cabib S, Puglisi-Allegra S (1998) Parallel strain-dependent effect of amphetamine on locomotor activity and dopamine release in the nucleus accumbens: an in vivo study in mice. Neuroscience 82:521-528